Lorlatinib CROWNed
- PMID: 33262501
- DOI: 10.1038/s41571-020-00458-w
Lorlatinib CROWNed
Comment on
-
First-Line Lorlatinib or Crizotinib in Advanced ALK-Positive Lung Cancer.N Engl J Med. 2020 Nov 19;383(21):2018-2029. doi: 10.1056/NEJMoa2027187. N Engl J Med. 2020. PMID: 33207094 Clinical Trial.
References
Original article
-
- Shaw, A. T. et al. First-Line lorlatinib or crizotinib in advanced ALK-positive lung cancer. N. Engl. J. Med. 383, 2018–2029 (2020) - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
